Profound Current Deferred Revenue from 2010 to 2026

PRN Stock  CAD 10.62  0.41  4.02%   
Profound Medical Current Deferred Revenue yearly trend continues to be very stable with very little volatility. Current Deferred Revenue is likely to drop to about 391.8 K. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2015-03-31
Previous Quarter
694 K
Current Value
434 K
Quarterly Volatility
6.1 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 718 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
This module can also supplement various Profound Medical Technical models . Check out the analysis of Profound Medical Correlation against competitors.
Evaluating Profound Medical's Current Deferred Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Profound Medical Corp's fundamental strength.

Latest Profound Medical's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of Profound Medical Corp over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Profound Medical's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

Profound Current Deferred Revenue Regression Statistics

Arithmetic Mean272,239
Geometric Mean0.00
Coefficient Of Variation82.84
Mean Deviation193,288
Median229,480
Standard Deviation225,530
Sample Variance50.9B
Range721K
R-Value0.88
Mean Square Error12.4B
R-Squared0.77
Slope39,220
Total Sum of Squares813.8B

Profound Current Deferred Revenue History

2026391.8 K
2025481.9 K
2024419 K
2023721 K
2022471 K
2021477 K
2020358 K

About Profound Medical Financial Statements

Profound Medical investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how Profound Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue481.9 K391.8 K

Pair Trading with Profound Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Profound Stock

  0.68TXG Torex Gold ResourcesPairCorr

Moving against Profound Stock

  0.64UBER Uber CDR SplitPairCorr
  0.32ABBV AbbVie CDRPairCorr
The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Profound Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.